Literature DB >> 4600045

Measurement of fibrinopeptide A in human blood.

H L Nossel, I Yudelman, R E Canfield, V P Butler, K Spanondis, G D Wilner, G D Qureshi.   

Abstract

Since thrombin cleaves fibrinopeptides A (FPA) and B from the NH(2)-terminal end of the fibrinogen molecule, measurement of fibrinopeptide levels in plasma may provide a direct index of thrombin action. Recently a radioimmunoassay for FPA has been developed, and in the present paper, we describe the application of this assay to the measurement of FPA levels in clinical blood samples. Since fibrinogen cross-reacts with antibodies to FPA, dialysis was used to extract the peptide from plasma. In vitro generation of FPA was prevented by removing the fibrinogen from the plasma by precipitation with ethanol before dialysis. The processing technique permitted recovery of 75% of FPA added to blood in vitro. Evidence that the immunoreactivity measured in plasma is due to FPA was provided by the results of experiments in which two antisera to FPA with different specificities showed comparable results and addition of thrombin caused no change in immunoreactivity. In contrast, extracts of streptokinasetreated plasma showed a five-fold increase in activity when treated with thrombin and markedly different immunoreactivity with the two antisera. Plasma FPA levels in 30 normal men were below 2 ng/ml, with a mean of 0.5 ng/ml. FPA levels in 12 patients with reduced fibrinogen levels or reduced platelet counts or both ranged between 4 and 289 ng/ml. FPA levels in 13 patients with normal or elevated fibrinogen levels, including 6 patients with clinical evidence of venous thrombosis or pulmonary embolism or both, ranged between 5 and 23 ng/ml. FPA and fibrinogen degradation product levels did not correlate, and in several patients, elevated FPA levels were found in the presence of normal fibrinogen degradation product levels. After infusion of FPA-containing solutions in four normal individuals, FPA showed a disappearance rate from the plasma consistent with a t((1/2)) of 3-5 min. Heparin infusions in six patients with venous thrombosis or pulmonary embolism or both and elevated FPA levels were followed by a prompt decline in FPA level at a mean rate equivalent to a 3-5 min t((1/2)).

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4600045      PMCID: PMC301523          DOI: 10.1172/JCI107749

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Clotting-fibrinolysis in a cavernous hemangioma.

Authors:  R S Hillman; L L Phillips
Journal:  Am J Dis Child       Date:  1967-06

Review 2.  Solid-phase peptide synthesis.

Authors:  R B Merrifield
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1969

3.  Studies on tissue thromboplastin, thrombin and fibrinopeptides in intravascular coagulation.

Authors:  A C Tiger-Nilsson
Journal:  Acta Physiol Scand Suppl       Date:  1968

4.  Blood hypercoagulability and thrombosis.

Authors:  A P Fletcher; N Alkjaersig; J O'Brien; V G Tulevski
Journal:  Trans Assoc Am Physicians       Date:  1970

5.  On the primary structure of human fibrinogen. Isolation and characterization of N-terminal fragments from plasmic digests.

Authors:  S Iwanaga; P Wallén; N J Gröndahl; A Henschen; B Blombäck
Journal:  Eur J Biochem       Date:  1969-03

6.  Radioimmunoassay of bradykinin: chemical modification to enable use of radioactive iodine.

Authors:  T L Goodfriend; D L Ball
Journal:  J Lab Clin Med       Date:  1969-03

7.  A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.

Authors:  C Merskey; P Lalezari; A J Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

8.  Activated coagulation factors: in-vivo and in-vitro studies.

Authors:  J Niemetz; H L Nossel
Journal:  Br J Haematol       Date:  1969-04       Impact factor: 6.998

9.  Human fibrinopeptides. Isolation, characterization and structure.

Authors:  B Blombäck; M Blombäck; P Edman; B Hessel
Journal:  Biochim Biophys Acta       Date:  1966-02-28

10.  Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125-I-labeled fibrinogen.

Authors:  Y Takeda
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

View more
  56 in total

1.  Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

Authors:  K A Bauer; L M Weiss; D Sparrow; P S Vokonas; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool.

Authors:  C Southan; D A Lane; I Knight; H Ireland; J Bottomley
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

4.  Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects.

Authors:  H J Weiss; V T Turitto; H R Baumgartner
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

5.  Importance of factor Xa in determining the procoagulant activity of whole-blood clots.

Authors:  P R Eisenberg; J E Siegel; D R Abendschein; J P Miletich
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor.

Authors:  J I Weitz; E K Silverman; B Thong; E J Campbell
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

7.  Human platelet-initiated formation and uptake of the C5-9 complex of human complement.

Authors:  T S Zimmerman; W P Kolb
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

8.  Two cases of the nephrotic syndrome with a reversible coagulation defect.

Authors:  M R Baker; J A Davies; G M Tate; M R Lee
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

9.  Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.

Authors:  S B Bilezikian; H L Nossel; V P Butler; R E Canfield
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.

Authors:  Manash S Chatterjee; William S Denney; Huiyan Jing; Scott L Diamond
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.